Dermatology Patient Pathways (Guidelines)

Warning

For Dermatology Patient Pathways click here

The National Dermatology Patient Pathways should be used in association with drug recommendations and guidance in this section to inform the management of acne, alopecia, atopic eczema, benign skin lesions, generalised and local pruritus, hand and foot eczema, molluscum contagiosum, nail dystrophy, non-melanoma skin cancers, psoriasis, rosacea, scabies, solar (actinic) keratoses and Bowen’s Disease, suspicious pigmented lesions, urticaria, and viral warts.

Editorial Information

Last reviewed: 10/11/2025

Next review date: 10/11/2028

Author(s): Dermatology .

Version: 1

Approved By: TAM subgroup of the ADTC

Reviewer name(s): Dr F Meredith Clinical Lead for Dermatology .

Document Id: TAM480